Yellow anionic disazo dyes

ABSTRACT

The present invention relates to novel yellow anionic dyes, a process for their preparation, certain novel intermediates necessary for their preparation and the use of these dyes for dyeing natural or synthetic materials, in particular, paper.

The present invention relates to novel yellow anionic dyes, a process for their preparation, certain novel intermediates necessary for their preparation and the use of these dyes for dyeing natural or synthetic materials, in particular, paper.

The use of diaminobenzanilides as building blocks for the synthesis of bisazo dyes and the advantages thereof has been described in Dyes and Pigments, 17, 297-302 (1991). On this basis, a number of bisazo orange and yellow dyes containing pyrazolones and phenolic derivatives as coupling components have been described, for example, in DE 818,669, DE 845,084, DE 2,362,995, GB 28,569, U.S. Pat. No. 2,228,321 and in JP 51-11817, whilst further symmetrical bisazo dyes containining 1-phenyl-5-amino pyrazoles have also been reported in U.S. Pat. No. 5,545,725, whilst U.S. Pat. No. 2,544,087 discloses certain bis-acetoacetanilide derivatives.

However, a requirement exists to provide further anionic dyes especially of neutral or greenish yellow shades, which dyes exhibit excellent degrees of exhaustion with high colour strength, whilst being sufficiently water-soluble to provide stable aqueous formulations without the need for large quantities of solubilizers. Furthermore, dyings obtained should exhibit high degrees of bleed- and light-fastness, be even- or top-sided and be readily bleachable.

Surprisingly, it has now been found that certain bisazo dyes based on diaminobenzanilides exhibit excellent effects with respect to the desired properties.

Accordingly, the invention relates to compounds of the formula

in which

-   R₁ represents hydrogen, substituted or unsubstituted C₁-C₈alkyl,     substituted or unsubstituted C₁-C₈alkoxy or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ and R_(3a) each, independently of the other, represent hydrogen,     a C₁-C₄alkyl group, which may be substituted or unsubstituted,     halogen, hydroxy, substituted or unsubstituted C₁-C₄alkoxy, carboxy,     NH₂ or NHC₁-C₄alkyl and each of the residues -   A₁ and A₂, independently of the other, is derived from a coupling     component selected from the group consisting of     -   an acetoacetylated amine of the formula         in which -   X₁ represents C₁-C₄alkyl, or phenyl which is unsubstituted or     monosubstituted by C₁-C₄alkyl, C₁-C₄alkoxy or halogen and -   X₂ represents phenyl which is unsubstituted, mono-, di- or     trisubstituted by one or two SO₃H, SO₂NHC₁-C₄ alkyl groups which     alkyl groups may be substituted, SO₂C₁-C₄alkyl, C₁-C₄substituted or     unsubstituted alkyl, hydroxy, C₁-C₄alkoxy, halogen, CF₃, NH₂,     NHCOC₁-C₄alkyl, NHCOOC₁-C₄alkyl, NHCONHC₁-C₄alkyl, CO₂H,     CONHC₁-C₄alkyl or NO₂; a 1- or 2-naphthyl residue which is     unsubstituted or substituted by one or two SO₃H, SO₂NHC₁-C₄alkyl,     carboxy, CONHC₁-C₄alkyl, carboxyC₁-C₄alkyl or carboxyaryl groups or     a 5- or 6-membered heterocyclic ring containing 1-3 heteroatoms and     which may be benzannelated and be further substituted by C₁-C₄alkyl,     C₁-C₄alkoxy or halogen and which may be attached to the NH-atom in     formula (2) either via the hetero- or benzo-nucleus, in the case of     benzannelated heterocycles; -   a derivative of barbituric acid of the formula     in which -   Y represents O, NCN or NCONH₂; -   a 2,4,6-triaminopyrimidine; -   a pyridone derivative of the formula     in which -   Q₁ represents hydrogen, hydroxy, C₁-C₂alkyl, hydroxyethyl,     2-(C₁-C₂alkoxy)alkyl, C₁-C₂alkoxy, COOH, CONH₂ or COO C₁-C₂alkyl, -   Q₂ represents hydrogen, CN, CONH₂, halogen, SO₃H or C₁-C₂alkyl which     is unsubstituted or substituted by hydroxy, phenyl or SO₃H, -   Q₃ represents hydrogen, phenyl, C₁-C₂alkylphenyl, cyclohexyl or     C₁-C₄alkyl which is unsubstituted or substituted by hydroxy, CN,     C₁-C₂alkoxy or SO₃H and -   Q₄ represents hydrogen or hydroxy; -   an aminopyrazole or a pyrazolone derivative of formula     in which -   R₄ represents hydrogen, substituted or unsubstituted C₁-C₄alkyl,     C₂-C₄alkenyl, NHCO C₁-C₄alkyl or CO₂H, each -   R₅ and R₆, independently of the other, represent hydrogen, halogen,     C₁-C₄alkyl, SO₃H or CO₂H and -   R₇ represents hydrogen or C₁-C₄alkyl; -   a benzoic acid derivative of formula     in which -   R₇ represents hydrogen or C₁-C₄alkyl and -   R₈ represents hydrogen or hydroxy or -   A₁ and A₂, each one independently of the other, represent a phenol     residue of the formula     in which -   R₉ and R₁₀, each one independently of the other, represent hydrogen,     C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen, NH₂, NHCO C₁-C₄alkyl,     NO₂, SO₃H, CO₂C₁-C₄alkyl or CONHC₁-C₄alkyl groups,     with the proviso that in compounds of formula     if -   R₁, R₂, R₃ and R_(3a) each, independently of the others, are     hydrogen or SO₃H, then -   A₁ and A₂ are not both a 1-phenyl or     1-sulphophenyl-3-methyl-5-aminopyrazole residue,     or, if -   R₁, R₂, R₃ and R_(3a) represent hydrogen and -   A₁ is a residue of formula (9) in which -   R₇ represents hydrogen or methyl, then -   A₂ does not represent a 1-phenyl or 1-sulphophenyl-3-methyl- or     3-carboxy pyrazol-5-one residue     or, if -   R₁, R₃ and R_(3a) are hydrogen and R₂ is SO₃H and one of -   A₁ and A₂ represents a 1-sulphophenyl-3-methylpyrazol-5-one residue,     then the other is, not a residue of formula (11) in which both -   R₉ and R₁₀ are hydrogen, or if -   A₁ represents a 1-nitrophenyl-, a 1-phenyl- or an unsubstituted     3-methylpyrazol-5-one residue, -   A₂ is not a residue of formula (9) in which R₇ represents hydrogen,     or if -   R₁, R₃ and R_(3a) represent hydrogen, R₂ is CO₂H and -   A₁ represents a residue of formula (9), in which R₇ is hydrogen, -   A₂ is not a residue of formula (2) or formula (7);     in compounds of the formula     if -   R₂ represents CO₂H, R₃ represents hydroxy or methoxy and R_(3a)     represents hydrogen, -   A₁ and A₂ do not represent residues of formulae (2) or (7) and,     in compounds of the formula     if -   R₂ represents SO₃H and R₃ and R_(3a) both represent hydrogen -   A₁ and A₂ are not both 2,4-dihydroxyphenyl.

In one preferred aspect of the invention, the compounds of formula (1), contain a total number of two, three or four SO₃H and/or CO₂H groups. These sulphonic and/or carboxylic acid groups may be represented either, as written, in the form of the free acid or in the salt form, SO₃M and/or CO₂M. M is preferably one equivalent of a colourless cation, typically lithium, sodium, potassium, ammonium or the protonated form of a C₄-C₁₂trialkylamine, C₄-C₁₂diamine, C₂-C₁₂alkanolamine or of a polyglycol amine, conveniently, triethanolamine trisglycol ether, or mixtures of such cationic species.

M as a protonated C₄-C₁₂trialkylamine may, for example, be a protonated N-ethyl-dimethylamine, N,N-diethylmethylamine, tri-n-propylamine, tri-n-butylamine, tri-isobutylamine, and, preferably, triethylamine or triisopropylamine.

M as a protonated C₄-C₁₂diamine may, for example, be ethylenediamine, or 1,3-diaminopropane, in which one or both nitrogen atoms are additionally substituted by one or two C₁-C₄alkyl radicals, preferably methyl or ethyl radicals. M is preferably an N,N-dialkylethylenediamine or N,N-dialkyl-1,3-diaminopropane. Illustrative examples are: N-ethylethylenediamine, N,N-dimethylethylenediamine, N,N′-dimethylethylenediamine, N,N-diethylethylenediamine, 3-dimethylamino-1-propylamine or 3-diethylamino-1-propylamine.

M as a protonated C₂-C₁₂alkanolamine may be the protonated form of a monoalkanolamine, dialkanolamine, monoalkanolmonoalkylamine, monoalkanoldialkylamine, dialkanolalkylamine or trialkanolamine or a mixture of different protonated alkanolamines. Illustrative examples are: protonated 2-aminoethanol, bis(2-hydroxyethyl)amine, N-(2-hydroxyethyl)dimethylamine, N-(2-hydroxyethyl)diethylamine, N,N-bis(2-hydroxyethyl)ethylamine or tris(2-hydroxyethyl)-amine.

One further preferred class of compounds of formula (1) is that of the formula

in which

-   R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy,     C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, -   R₃, represents hydrogen or NH₂ and -   A₁ and A₂ are as defined above.

More preferably, however, in the above compounds of formula (13),

-   R₃ and R_(3a) both represent hydrogen and -   A₁ and A₂, each one independently of the other, is derived from a     coupling component selected from the group consisting of     an acetoacetylated amine of the formula     in which -   X₁ represents C₁-C₄alkyl, and -   X₂ represents phenyl, which is unsubstituted, mono-, di- or     trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or     CO₂H; -   barbituric acid or cyanoiminobarbituric acid; -   2,4,6-triaminopyrimidine; -   citrazinic acid;     a pyridone derivative of the formula     in which -   Q₁ represents C₁-C₂alkyl, -   Q₂ represents CN, CONH₂ or CH₂SO₃H, -   Q₃ represents C₁-C₂alkyl and -   Q₄ represents hydroxy;     an aminopyrazole or a pyrazolone derivative of formula     in which -   R₄ represents C₁-C₄alkyl or CO₂H, -   R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and -   R₆ represents hydrogen;     a benzoic acid derivative of formula     in which -   R₇ represents hydrogen or C₁-C₄alkyl and -   R₈ represents hydrogen or hydroxy or -   A₁ and A₂, each one independently of the other, represent a phenol     residue of the formula     in which -   R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or     SO₃H and -   R₁₀ represents hydrogen.

Most preferred compounds of formula (13) are those in which

-   R₁ represents hydrogen, C₁-C₄alkoxy, especially methoxy, or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ and R_(3a) both represent hydrogen and the coupling component A₁     is derived from an acetoacetylated amine of formula (2), barbituric     acid or cyanimino barbituric acid, a pyridone derivative of     formula (4) in which Q₁ represents methyl, Q₂ is CN, CONH₂ or     CH₂SO₃H, Q₃ is ethyl or methyl and 04 is hydroxy, a compound of     formula (5) or (7) in which R₄ represents C₁-C₄alkyl, especially     methyl, R₅ represents hydrogen or SO₃H and -   R₆ represents hydrogen, or from salicyclic acid and the coupling     component A₂ is derived from an acetoacetylated amine of formula     (2), whereby, in formula (2), X₁ preferably represents methyl and X₂     preferably represents phenyl, which is monosubstituted by SO₃H or     trisubstituted by SO₃H, methyl and methoxy or A₂ is is derived from     a pyridone derivative of formula (4) in which Q, represents methyl,     Q₂ is CN, CONH₂ or CH₂SO₃H, Q₃ is ethyl and Q₄ is hydroxy or from an     aminpyrazole of formula (5) in which R₄ represents C₁-C₄alkyl,     especially methyl, R₅ represents hydrogen or SO₃H and R₆ represents     hydrogen.

A second preferred class of compounds of formula (1) is that of the formula

in which

-   R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy,     C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, -   R_(3a) represents hydrogen or NH₂ and -   A₁ and A₂ are as defined for formula (1) above.

More preferably, however, in the above compounds of formula (14)

-   R₃ and R_(3a) both represent hydrogen and -   A₁ and A₂, each one independently of the other, is derived from a     coupling component selected from the group consisting of     an acetoacetylated amine of the formula     in which -   X₁ represents C₁-C₄alkyl, and -   X₂ represents phenyl, which is unsubstituted, mono-, di- or     trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or     CO₂H; -   barbituric acid or cyanoiminobarbituric acid; -   2,4,6-triaminopyrimidine; -   citrazinic acid;     an aminopyrazole or a pyrazolone derivative of formula     in which -   R₄ represents C₁-C₄alkyl or CO₂H, -   R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and -   R₆ represents hydrogen;     a benzoic acid derivative of formula     in which -   R₇ represents hydrogen or C₁-C₄alkyl and -   R₈ represents hydrogen or hydroxy or -   A₁ and A₂, each one independently of the other, represent a phenol     residue of the formula     in which -   R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or     SO₃H and -   R₁₀ represents hydrogen.

Most preferred compounds of formula (14) are those in which

-   R₁ represents hydrogen, C₁-C₄alkoxy, especially methoxy, or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ and R_(3a) both represent hydrogen and the coupling component A₁     is derived from an acetoacetylated amine of formula (2), barbituric     acid, cyanoiminobarbituric acid, 2,4,6-triaminopyrimidine,     citrazinic acid, a compound of formula (5) or (7) in which R₄     represents C₁-C₄alkyl, especially methyl, R₅ represents hydrogen or     SO₃H and R₆ represents hydrogen or from salicyclic acid, methyl     salicyclic acid, phenol or methyl phenol and the coupling component     A₂ is is derived from an acetoacetylated amine of formula (2),     whereby, in formula (2), X₁ preferably represents methyl and X₂     preferably represents phenyl, which is monosubstituted by SO₃H or,     especially, trisubstituted by SO₃H, methyl and methoxy or A₂ is     derived from an aminpyrazole of formula (5) in which R₄ represents     C₁-C₄alkyl, especially methyl, R₅ represents hydrogen or SO₃H and R₆     represents hydrogen.

A third preferred class of compounds of formula (1) is that of formula

in which

-   R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy,     C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, -   R_(3a) represents hydrogen or NH₂ and -   A₁ and A₂ are as defined for formula (1) above.

More preferably, however, in the above compounds of formula (15)

-   R₃ and R_(3a) both represent hydrogen and -   A₁ and A₂, each one independently of the other, is derived from a     coupling component selected from the group consisting of     an acetoacetylated amine of the formula     in which -   X₁ represents C₁-C₄alkyl, and -   X₂ represents phenyl, which is unsubstituted, mono-, di- or     trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or     CO₂H; -   barbituric acid or cyanoiminobarbituric acid; -   2,4,6-triaminopyrimidine; -   citrazinic acid;     an aminopyrazole or a pyrazolone derivative of formula     in which -   R₄ represents C₁-C₄alkyl or CO₂H, -   R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and -   R₆ represents hydrogen;     a benzoic acid derivative of formula     in which -   R₇ represents hydrogen or C₁-C₄alkyl and -   R₈ represents hydrogen or hydroxy or -   A₁ and A₂, each one independently of the other, represent a phenol     residue of the formula     in which -   R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or     SO₃H and -   R₁₀ represents hydrogen.

Most preferred compounds of formula (15) are those in which

-   R₁ represents hydrogen or C₁-C₄alkoxy, especially hydrogen, -   R₂ represents SO₃H or CO₂H, especially SO₃H, -   R₃ and R_(u) both represent hydrogen and the coupling component A₁     is derived from an acetoacetylated amine of formula (2), barbituric     acid, cyanoiminobarbituric acid, triaminopyrimidine, citrazinic     acid, a compound of formula (5) or (7) in which R₄ represents     C₁-C₄alkyl, especially methyl, R₅ represents hydrogen or SO₃H and -   R₆ represents hydrogen or from salicyclic acid, methyl salicyclic     acid, phenol or methyl phenol and the coupling component A₂ is is     derived from an acetoacetylated amine of formula (2), whereby, in     formula (2), X₁ preferably represents methyl and X₂ preferably     represents phenyl, which is monosubstituted by SO₃H or, especially,     trisubstituted by SO₃H, methyl and methoxy or A₂ is derived from an     aminpyrazole of formula (5) in which R₄ represents C₁-C₄alkyl,     especially methyl, R₅ represents hydrogen or SO₃H and R₆ represents     hydrogen.

A fourth preferred class of compounds of formula (1) is that of formula

in which

-   R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, -   R₂ represents SO₃H or CO₂H, -   R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy,     C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, -   R_(3a) represents hydrogen or NH₂ and -   A₁ and A₂ are as defined for formula (1) above.

More preferably, however, in the above compounds of formula (16),

-   R₃ and R₃₈ both represent hydrogen and -   A₁ and A₂, each one independently of the other, is derived from a     coupling component selected from the group consisting of     an acetoacetylated amine of the formula     in which -   X₁ represents C₁-C₄alkyl, and -   X₂ represents phenyl, which is unsubstituted, mono-, di- or     trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or     CO₂H; -   barbituric acid or cyanoiminobarbituric acid; -   2,4,6-triaminopyrimidine; -   citrazinic acid;     an aminopyrazole or a pyrazolone derivative of formula     in which -   R₄ represents C₁-C₄alkyl or CO₂H, -   R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and -   R₆ represents hydrogen;     a benzoic acid derivative of formula     in which -   R₇ represents hydrogen or C₁-C₄alkyl and -   R₈ represents hydrogen or hydroxy or -   A₁ and A₂, each one independently of the other, represent a phenol     residue of the formula     in which -   R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or     SO₃H and -   R₁₀ represents hydrogen.

Most preferred compounds of formula (16) are those in which

-   R₁ represents hydrogen or C₁-C₄alkoxy, especially hydrogen, -   R₂ represents SO₃H or CO₂H, especially SO₃H, -   R₃ and R_(3a) both represent hydrogen and the coupling component A₁     is derived from an acetoacetylated amine of formula (2), barbituric     acid, cyanoiminobarbituric acid, 2,4,6-triaminopyrimidine,     citrazinic acid, a compound of formula (5) or (7) in which R₄     represents C₁-C₄alkyl, especially methyl, R₅ represents hydrogen or     SO₃H and -   R₆ represents hydrogen or from salicyclic acid, methyl salicyclic     acid, phenol or methyl phenol and the coupling component A₂ is     derived from an acetoacetylated amine of formula (2), whereby, in     formula (2), X₁ preferably represents methyl and X₂ preferably     represents phenyl, which is monosubstituted by SO₃H or, especially,     trisubstituted by SO₃H, methyl and methoxy or A₂ is is derived form     an aminpyrazole of formula (5) in which R₄ represents C₁-C₄alkyl,     especially methyl, R₅ represents hydrogen or SO₃H and R₆ represents     hydrogen.

Within the scope of the definitions of the above formulae and radicals (1) to (16), a C₁-C₈alkyl radical may be branched or unbranched, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, t-butyl, 2-ethylbutyl, n-pentyl, isopentyl, 1-methylpentyl, 1,3-dimethylbutyl, n-hexyl, 1-methylhexyl, n-heptyl, isoheptyl, 1,1,3,3-tetramethylbutyl, 1-methylheptyl, 3-methylheptyl, n-octyl or 2-ethylhexyl.

Similarly, C₁-C₈alkoxy may be, for example, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, t-butoxy, 2-ethylbutoxy, n-pentoxy, isopentoxy, 1-methylpentoxy, 1,3-dimethylbutoxy, n-hexyloxy, 1-methylhexyloxy, n-heptyloxy, isoheptyloxy, 1,1,3,3-tetramethylbutoxy. 1-methylheptyloxy, 3-methylheptyloxy, n-octyloxy or 2-ethylhexyloxy.

When such alkyl or alkoxy radicals are substituted, appropriate substituents may typically include one or two hydroxy, SO₃H, carboxy, C₁-C₄alkoxy, hydoxy-substituted C₁-C₄alkoxy, phenyl or phenoxy groups. Suitable radicals of this type may include hydroxyethyl, 1-hydroxyisopropyl, ethoxymethyl, 2-hydroxyethoxypentyl, benzyl, 1-phenylethyl, 2-phenylethyl, 1-methyl-2-phenylethyl, 1-isobutyl-3-phenylpropyl or 1-methyl-2-phenoxyethyl.

Halogen in the above formulae and radicals is iodine, bromine, fluorine or, especially, chlorine.

Where, in the derivatives of formulae (4) and (5), R₄ represents C₂-C₄alkenyl, this may, for example, be ethenyl, n-propenyl, isopropenyl, n-butenyl or isobutenyl.

Where, in the acetoacetylated amines of formula (2), X₂ represents a 5- or 6-membered heterocyclic ring containing 1-3 heteroatoms and which may be benzannelated, these may be, for example, oxazol-2-yl, thiazol-2-yl, benzoxazol-2-, 5-, or 6-yl, benzothiazol-2-, 5- or 6-yl, benzimidazolone-5-yl, pyrid-2,3- or 4-yl, quinolin-2-, 4-, 5- or 6-yl or 1,3,5-triazin-2-yl radicals.

The dyes of formula (1) of the invention may be prepared by known methods, for example by tetrazotisation of a diaminobenzanilide derivative of the formula

in which R₁, R₂, R₃ and R_(3a) are as defined for formula (1), and sequential coupling with a coupling component of the formula A₁H or A₂H, followed by coupling with a coupling component of the formula A₂H or A₁H, A₂ and A₁ being as defined for formula (1).

Such sequential coupling reactions have been described previously (see, for example, U.S. Pat. No. 5,545,725). However, it is advantageous to perform the initial coupling reaction at a pH value of between 2 and 5, especially between 2.5 and 4, whilst the subsequent coupling reaction is performed at a pH value of between 5 and 9, preferably between 6 and 8.

The coupling components A₁H and A₂H are known compounds or may be prepared by known methods, whilst some of the diaminobenzanilides of formula (14) are novel. Consequently, a further aspect of the invention is a compound of the formula

preferably 4,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid or 3,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid, a process for the preparation thereof, by reaction of 2-methoxy-4-nitroaniline-5-sulphonic acid with the appropriate nitrobenzoyl halide, preferably m- or p-nitrobenzoyl chloride, followed by reduction of the resulting dinitrobenzanilide by known methods and also the use of the compound (18) for the preparation of the appropriate compound of formula (1).

The dyes of the invention may be used to dye natural or synthetic materials, for example, cellulosic materials, carbonamide group containing materials such as polyamides, leather or glass fibres, but are particularly useful for dyeing paper. They are preferably used as a solid or liquid commercial form.

The pulverulent or granular form of the dye is used particularly in batchwise pulp dyeing where the dye mixture, customarily in the form of a stock solution, is added in the pulper, in the beater or in the mixing chest. Preference is here given to using dye preparations which as well as the dye, may further include extenders, for example urea as solubilizer, dextrin, Glauber salt, sodium chloride and also dispersants, dustproofing agents and sequestrants, such as tetrasodium phosphate.

The present invention accordingly further provides solid dye preparations for dyeing paper comprising a compound of the formula (1) and, optionally, further auxiliaries.

In recent years, the use of concentrated aqueous solutions of dyes has gained importance because of the advantages possessed by such solutions when compared with dyes in powder form. The use of solutions avoids the difficulties associated with dust formation and releases the user from the time-consuming and frequently difficult dissolving of the dye powder in water. The use of concentrated solutions was also prompted by the development of continuous dyeing processes for paper, since it is convenient in these processes to meter the solution directly into the pulp stream or to add it at some other suitable point of the paper-making process.

The present invention accordingly further provides aqueous solutions, preferably concentrated solutions, for dyeing paper, comprising a compound of the formula (1), preferably in a concentration of from 5 to 30% by weight. Due to their excellent solubility in water, the dyes of formula (1) are particularly suitable for the preparation of such solutions.

The concentrated solutions preferably contain a low level of inorganic salts, which may be achieved, if necessary, by known methods, for example reverse osmosis.

The solutions may include further auxiliaries, for example solubilizers such as ε-caprolactam or urea, organic solvents, for example glycols, polyethylene glycols, dimethyl sulphoxide, N-methylpyrrolidone, acetamide, alkanolamines or polyglycolamines, which is a still further aspect of the invention.

In addition, the aqueous dye solutions of the present invention may be applied to paper by use of the so-called spraying technique.

The novel dyes of the invention dye paper in predominantly yellow shades with excellent degrees of exhaustion with high colour strength, whilst being sufficiently water-soluble to provide stable aqueous formulations without the need for large quantities of solubilizers. Furthermore, dyings obtained exhibit high degrees of bleed- and light-fastness, are even- or top-sided and readily bleachable.

Furthermore, as a result of their high colour strength and water solubility, the novel dyes of the invention are suitable for use in the ink-jet printing method.

Consequently, one further aspect of the invention is paper which is dyed with a compound of the formula (1), either in the form of a solid dye preparation, or an aqueous solution, as described above.

The following Examples serve to illustrate the invention without intending to be restrictive in nature. Parts and percentages are by weight unless otherwise stated.

Synthesis of Intermediate Diaminobenzanilides

EXAMPLE 1

73.5 g of p-penylenediamine 2-sulphonic acid are added to 300 g of water and, after addition of approximately 40 g of sodium carbonate, the violet suspension is stirred until solution results. The pH is adjusted to 7.5 by addition of concentrated hydrochloric acid and a solution of 78 g of p-nitrobenzoyl chloride in 100 ml of acetone then added slowly at 25-32° C., the pH being maintained at 6.7-7.0 by addition of 2N aqueous sodium hydroxide. After stirring for a further 1.5 hours, 210 ml of water are added and the pH adjusted to 4.0 by addition of 22 ml of concentrated hydrochloric acid. The readily stirrable suspension is filtered at room temperature and washed with 200 ml of water. The filter cake is then stirred in water at 50° C., filtered hot and dried to yield 75 g of 4′amino-4-nitrobenzanilide 3-sulphonic acid.

A mixture of 1300 g of water, 46.2 g of iron filings and 5.8 g of ammonium chloride is heated to boiling with vigorous stirring and then treated with 55 g of of 4′amino-4-nitrobenzanilide 3-sulphonic acid, obtained as described above. The resulting suspension is stirred for a further 1 hour at 95-100° C. and, subsequently, cooled to room temperature. The suspension is filtered hot and the filtrate stirred with 5 g of Hyflo Carcel™ for 30 minutes at room temperature. After filtering, the pH of the hot filtrate is adjusted to 2.0 by addition of 18 g of concentrated hydrochloric acid and the white precipitate filtered and dried. There are obtained 39 g of 4,4′diaminobenzanilide 5′-sulphonic acid of formula (100a).

EXAMPLE 2

74.5 g of 2-methoxy-4-nitroaniline 5-sulphonic acid are added to 300 g of water and, after addition of approximately 30 g of sodium carbonate, the yellowish orange suspension is stirred until solution results. The pH is adjusted to 7.0 by addition of concentrated hydrochloric acid and a solution of 60 g of p-nitrobenzoyl chloride in 75 ml of acetone then added slowly below 28° C., the pH being maintained at 6.7-7.0 by addition of 2N aqueous sodium hydroxide. After stirring for a further 2 hours, 650 g of water are added and the pH adjusted to 4.0 by addition of 2N aqueous hydrochloric acid. The readily stirrable suspension is filtered, the filter cake washed with 200 g of water and sucked dry. There are obtained 391 g of damp filter cake, which is used directly for the next step.

A mixture of 1000 g of water, 60 g of iron filings and 7.6 g of ammonium chloride is heated to boiling with vigorous stirring and then treated with 145 g of the damp filter cake, obtained as described above. The resulting suspension is stirred for a further 2 hours at 90-95° C. and, subsequently, 700 g of water are added. The suspension is filtered hot and the filtrate stirred with 10 g of Hyflo Supercel™ for 30 minutes at 85° C. After filtering, the pH of the hot filtrate is adjusted to 3.8 by addition of 24 g of concentrated hydrochloric acid and the white precipitate filtered and dried. There are obtained 34.3 g of 4,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid of formula (100b).

EXAMPLES 3-10

By following the procedure described in Examples 1 or 2, employing appropriate starting materials, the following benzanilides may be obtained, as summarized in Table 1 below. TABLE 1 Ex- Com- ample pound Nr. Nr Formula 3 (100c)

4 (100d)

5 (100e)

6 (100f)

7 (100g)

8 (100h)

9 (100i)

10 (100j)

Synthesis of Dyes

EXAMPLE 11

3.1 g of the compound of formula (100a) are suspended in 50 g of water and 5.7 g of concentrated hydrochloric acid and subsequently treated with 4.75 ml of a 4N aqueous sodium nitrite solution at 0-5° C. over a period of 1 hour. The mixture is stirred for a further 1 hour and excess nitrite then destroyed by addition of 0.3 ml of 2N sulphamic acid. The resultant beige suspension is diluted with 60 g of water and then treated with a total of 2.4 g of 5-amino-3-methyl-1-(3-sulphophenyl)pyrazole, in portions, at 5° C., the pH being maintained at 3.6-4.0 by addition of a total of 13.7 ml of 2N aqueous sodium hydroxide solution. The resulting monoazo suspension is then added slowly, during 70 minutes, to a solution of 1.7 g of 5-amino-3-methyl-1-phenyl pyrazole dissolved in 50 g of water and 50 g of dimethyl formamide, the pH being maintained at 6.5 by addition of a total of 11.9 ml of 2N aqueous sodium hydroxide solution. After stirring for a further 1.5 hours at room temperature, 50 ml of isopropanol and 30 g of sodium chloride are added, the mixture stirred for 1 hour and the resulting yellowish brown suspension filtered. After drying, there are obtained 6.7 g of the compound of formula (101).

EXAMPLE 12

3.1 g of the compound of formula (100a) are suspended in 50 g of water and 5.7 g of concentrated hydrochloric acid and subsequently treated with 4.75 ml of a 4N aqueous sodium nitrite solution at 0-5° C. over a period of 1 hour. The mixture is stirred for a further 1 hour and excess nitrite then destroyed by addition of 0.3 ml of 2N sulphamic acid. The resultant beige suspension is diluted with 60 g of water and then treated with 1.75 g of 5-amino-3-methyl-1-phenyl pyrazole and reaction continued for 2.5 hours at 5° C., the pH being maintained at 3.8-4.0 by addition of a total of 15.9 ml of 2N aqueous sodium hydroxide solution. The resulting monoazo suspension is then added slowly, during 2.5 hours, to a solution of 3.0 g of 3-acetoacetylamino-4-methoxy toluene 6-sulphonic acid dissolved in 50 g of water and 50 g of dimethyl formamide, the pH being maintained at 6.8 by addition of a total of 7 ml of 2N aqueous sodium hydroxide solution. After stirring for a further 1.5 hours at 30-35° C., 75 ml of isopropanol and 45 g of sodium chloride are added and the resulting yellow suspension filtered. After drying, there are obtained 6.8 g of the compound of formula (102).

EXAMPLE 13

3.1 g of the compound of formula (100a) are suspended in 50 g of water and 5.7 g of concentrated hydrochloric acid and subsequently treated with 4.75 ml of a 4N aqueous sodium nitrite solution at 0-5° C. over a period of 1 hour. The mixture is stirred for a further 1 hour and excess nitrite then destroyed by addition of 0.3 ml of 2N sulphamic acid. The resultant beige suspension is diluted with 60 g of water and then treated with 1.2 g of barbituric acid. The pH is raised to 2.5 and then maintained at 2.3-2.5 over a period of 3 hours by addition of a total of 5.1 ml of 4N aqueous sodium hydroxide solution. The resulting monoazo suspension is then added slowly, during 1.5 hours, to a solution of 3.5 g of 3-acetoacetylamino-4-methoxy toluene 6-sulphonic acid dissolved in 100 g of water, the pH being maintained at 6.5 by addition of a total of 5.4 ml of 4N aqueous sodium hydroxide solution. After stirring for a further 2.5 hours at room temperature, 75 ml of isopropanol and 15 g of sodium chloride are added and, after stirring briefly at room temperature, the resulting yellowish red suspension is filtered. After drying, there are obtained 7.1 g of the compound of formula (103).

EXAMPLE 14

3.1 g of the compound of formula (100a) are suspended in 50 g of water and 5.7 g of concentrated hydrochloric acid and subsequently treated with 4.75 ml of a 4N aqueous sodium nitrite solution at 0-5° C. over a period of 1 hour. The mixture is stirred for a further 1 hour and excess nitrite then destroyed by addition of 0.3 ml of 2N sulphamic acid. The resultant beige suspension is filtered and the moist presscake suspended in 110 ml of water. 1.75 g of 3-methyl-1-phenyl pyrazo-2-one are added and the pH raised to 3.7. By the addition of a total of 2.5 ml of 4N aqueous sodium hydroxide solution, the pH is maintained at 3.5-4.0, whilst the temperature is raised stepwise from 10° C. to 30° C. After stirring for a total of 3.5 hours the coupling reaction is complete. To the resulting monoazo suspension are then added 50 g of dimethyl formamide followed by 3.5 g of 3-acetoacetylamino-4-methoxy toluene 6-sulphonic acid. The pH is adjusted to 7.0-7.5 and maintained at this value by addition of a further 2.7 ml of 4N aqueous sodium hydroxide solution. After stirring for a further 2 hours at room temperature, 20 g of sodium chloride are added, the mixture stirred for 1 hour at room temperature and the resulting yellow suspension filtered. After drying, there are obtained 5.5 g of the compound of formula (104).

EXAMPLE 15

3.1 g of the compound of formula (100a) are suspended in 50 g of water and 5.7 g of concentrated hydrochloric acid and subsequently treated with 4.75 ml of a 4N aqueous sodium nitrite solution at 0-5° C. over a period of 1 hour. The mixture is stirred for a further 1 hour and excess nitrite then destroyed by addition of 0.3 ml of 2N sulphamic acid. The resultant beige suspension is filtered and the moist presscake suspended in 110 ml of water. 1.4 g of salicylic acid are added and the pH raised to 3.0-3.3. By the addition of a total of 4.9 ml of 2N aqueous sodium hydroxide solution, the pH is maintained at 3.0-3.5. After stirring for a total of 2.5 hours at room temperature the coupling reaction is complete. To the resulting monoazo suspension are then added 3.5 g of 3-acetoacetylamino-4-methoxy toluene 6-sulphonic acid. The pH is adjusted to 6.5 and maintained at this value by addition of a further 4.9 ml of 2N aqueous sodium hydroxide solution. After stirring for a total of 3.5 hours at room temperature, 10 g of sodium chloride and 15 ml of isopropanol are added, the pH increased to 8.5 and the resulting yellowish brown suspension filtered. After drying, there are obtained 5.2 g of the compound of formula (105).

EXAMPLE 16-116

By proceeding in an analogous manner to that described in Examples 11-15, but utilizing the appropriate coupling components, compounds of formula (19) are obtained, as summarized in the following Table 2. TABLE 2 (19)

Example Nr. Compound Nr. A′₁ A′₂ 16 (106)

17 (107)

18 (108)

19 (109)

20 (110)

21 (111)

22 (112)

23 (113)

24 (114)

25 (115)

26 (116)

27 (117)

28 (118)

29 (119)

30 (120)

31 (121)

32 (122)

33 (123)

34 (124)

35 (125)

36 (126)

37 (127)

38 (128)

39 (129)

40 (130)

41 (131)

42 (132)

43 (133)

44 (134)

45 (135)

46 (136)

47 (137)

48 (138)

49 (139)

50 (140)

51 (141)

52 (142)

53 (143)

54 (144)

55 (145)

56 (146)

57 (147)

58 (148)

59 (149)

60 (150)

61 (151)

62 (152)

63 (153)

64 (154)

65 (155)

66 (156)

67 (157)

68 (158)

69 (159)

70 (160)

71 (161)

72 (162)

73 (163)

74 (164)

75 (165)

76 (166)

77 (167)

78 (168)

79 (169)

80 (170)

81 (171)

82 (172)

83 (173)

84 (174)

85 (175)

86 (176)

87 (177)

88 (178)

89 (179)

90 (180)

91 (181)

92 (182)

93 (183)

94 (184)

95 (185)

96 (186)

97 (187)

98 (188)

99 (189)

100 (190)

101 (191)

102 (192)

103 (193)

104 (194)

105 (195)

106 (196)

107 (197)

108 (198)

109 (199)

110 (200)

111 (201)

112 (202)

113 (203)

114 (204)

115 (205)

116 (206)

117 (207)

118 (208)

119 (209)

120 (210)

121 (211)

122 (212)

123 (213)

EXAMPLE 124

4.5 g of 4,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid of formula (100b), prepared as described in Example 2, are suspended in 50 g of water and 7.6 g of concentrated hydrochloric acid and subsequently treated with 5.7 ml of 4N aqueous sodium nitrite solution over 1 hour at 0-5° C. The mixture is stirred for a further 1 hour and excess nitrite destroyed by addition of 0.8 ml of 2N aqueous sulphamic acid solution. The resulting yellow suspension is diluted with 60 g of water and treated with 2.9 g of 5-amino-3-methyl-1-(3-sulphophenyl) pyrazole at 5° C., the pH being initially raised to 3.5 and maintained at 3.0-3-5 by the addition of a total of 27.4 ml of 2N aqueous sodium hydroxide solution. After stirring for 2.5 hours the initial coupling reaction is completed. The resulting monoazo suspension is slowly added to a solution of 4.0 g of 3-acetacetylamino-4-methoxytoluene 6-sulphonic acid in 50 g of dimethylformamide over 2.5 hours at 30° C., the pH being maintained at 6.8-7.0 by addition of a total of 7.3 ml of 4N aqueous sodium hydroxide solution. After stirring for 1.5 hours at 30° C., 35 g of sodium chloride and 50 g of isopropanol are added, the mixture stirred over night and the precipitated solids filtered. After drying, there are obtained 10.2 g of the compound of formula (214).

EXAMPLE 125

4.5 g of 4,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid of formula (100b), prepared as described in Example 2, are suspended in 50 g of water and 7.6 g of concentrated hydrochloric acid and subsequently treated with 5.7 ml of 4N aqueous sodium nitrite solution over 1 hour at 0-5° C. The mixture is stirred for a further 1 hour and excess nitrite destroyed by addition of 0.8 ml of 2N aqueous sulphamic acid solution. The resulting yellow suspension is added to a solution of 7.7 g of 3-acetacetylamino-4-methoxytoluene 6-sulphonic acid in 100 g of water over 30 minutes at 5° C., the pH being of which is initially adjusted to 3.8 and is maintained at 3.8-4.0 by the addition of a total of 22.6 ml of 2N aqueous sodium hydroxide solution. Subsequently, the pH is raised to 6.8-7.4 by addition of a further 10.1 ml of 2N aqueous sodium hydroxide solution and the temperature increased to 25-40° C. After stirring for a total of 3 hours, 45 g of potassium chloride and 50 g of isopropanol are added and the precipitated solids filtered. After drying, there are obtained 12.9 g of the compound of formula (215).

EXAMPLE 126

2.1 g of 4,4′diamino-2′-methoxybenzanilide 5′-sulphonic acid of formula (100b), prepared as described in Example 2, are suspended in 50 g of water and 7.6 g of concentrated hydrochloric acid and subsequently treated with 5.7 ml of 4N aqueous sodium nitrite solution over 1 hour at 0-5° C. The mixture is stirred for a further 1 hour and excess nitrite destroyed by addition of 2N aqueous sulphamic acid solution. The resulting yellow solution is treated with 0.9 g of 5-amino-3-methyl-1-phenyl pyrazole at 5° C., the pH being initially raised to 3.0 and maintained at 2.5-3.0 by the addition of a total of 3.1 ml of 4N aqueous sodium hydroxide solution. After stirring for 2.5 hours and slowly warming to 20° C., the initial coupling reaction is completed. To the resulting monoazo suspension are added 1.7 g of 3-acetacetylamino-4-methoxytoluene 6-sulphonic acid, the pH raised to 6.5 and maintained at 6.0-7.5 by addition of a total of 2.2 ml of 4N aqueous sodium hydroxide solution. After stirring for 3 hours at 20-40° C. reaction is complete and the precipitated solids are filtered. After drying, there are obtained 5.4 g of the compound of formula (216).

EXAMPLES 127-198

By proceeding in an analogous manner to that described in Examples 124-126, but utilizing the appropriate coupling components, compounds of formula (20) are obtained, as summarized in the following Table 3. TABLE 3 (20)

Example Nr. Compound Nr. A′₁ A′₂ 127 (217)

128 (218)

129 (219)

130 (220)

131 (221)

132 (222)

133 (223)

134 (224)

135 (225)

136 (226)

137 (227)

138 (228)

139 (229)

140 (230)

141 (231)

142 (232)

143 (233)

144 (234)

145 (235)

146 (236)

147 (237)

148 (238)

149 (239)

150 (240)

151 (241)

152 (242)

153 (243)

154 (244)

155 (245)

156 (246)

157 (247)

158 (248)

159 (249)

160 (250)

161 (251)

162 (252)

163 (253)

164 (254)

165 (255)

166 (256)

167 (257)

168 (258)

169 (259)

170 (260)

171 (261)

172 (262)

173 (263)

174 (264)

175 (265)

176 (266)

177 (267)

178 (268)

179 (269)

180 (270)

181 (271)

182 (272)

183 (273)

184 (274)

185 (275)

186 (276)

187 (277)

188 (278)

189 (279)

190 (280)

191 (281)

192 (282)

193 (283)

194 (284)

195 (285)

196 (286)

197 (287)

198 (288)

EXAMPLES 199-217

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100c) and utilizing the appropriate coupling components, compounds of formula (21) are obtained, as summarized in the following Table 4. TABLE 4 (21)

Example Nr. Compound Nr. A′₁ A′₂ 199 (289)

200 (290)

201 (291)

202 (292)

203 (293)

204 (294)

205 (295)

206 (296)

207 (297)

208 (298)

209 (299)

210 (300)

211 (301)

212 (302)

213 (303)

214 (304)

215 (305)

216 (306)

217 (307)

EXAMPLE 218-236

By proceeding in an analogous manner to that described in Examples 124-126, but replacing the compound of formula (100b) by the compound of formula (100d) and utilizing the appropriate coupling components, compounds of formula (22) are obtained, as summarized in the following Table 5. TABLE 5 (22)

Example Nr. Compound Nr. A′₁ A′₂ 218 (308)

219 (309)

220 (310)

221 (311)

222 (312)

223 (313)

224 (314)

225 (315)

226 (316)

227 (317)

228 (318)

229 (319)

230 (320)

231 (321)

232 (322)

233 (323)

234 (324)

235 (325)

236 (326)

EXAMPLE 237-255

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100e) and utilizing the appropriate coupling components, compounds of formula (23) are obtained, as summarized in the following Table 6. TABLE 6 (23)

Example Nr. Compound Nr. A′₁ A′₂ 237 (327)

238 (328)

239 (329)

240 (330)

241 (331)

242 (332)

243 (333)

244 (334)

245 (335)

246 (336)

247 (337)

248 (338)

249 (339)

250 (340)

251 (341)

252 (342)

253 (343)

254 (344)

255 (345)

EXAMPLES 256-274

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100f) and utilizing the appropriate coupling components, compounds of formula (24) are obtained, as summarized in the following Table 7. TABLE 7 (24)

Example Nr. Compound Nr. A′₁ A′₂ 256 (346)

257 (347)

258 (348)

259 (349)

260 (350)

261 (351)

262 (352)

263 (353)

264 (354)

265 (355)

266 (356)

267 (357)

268 (358)

269 (359)

270 (360)

271 (361)

272 (362)

273 (363)

274 (364)

EXAMPLE 275-286

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100g) and utilizing the appropriate coupling components, compounds of formula (25) are obtained, as summarized in the following Table 8. TABLE 8 (25)

Example Nr. Compound Nr. A′₁ A′₂ 275 (365)

276 (366)

277 (367)

278 (368)

279 (369)

280 (370)

281 (371)

282 (372)

283 (373)

284 (374)

285 (375)

286 (376)

EXAMPLES 287-298

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100h) and utilizing the appropriate coupling components, compounds of formula (26) are obtained, as summarized in the following Table 9. TABLE 9 (26)

Example Nr. Compound Nr. A′₁ A′₂ 287 (377)

288 (378)

289 (379)

290 (380)

291 (381)

292 (382)

293 (383)

294 (384)

295 (385)

296 (386)

297 (387)

298 (388)

EXAMPLE 299-365

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100i) and utilizing the appropriate coupling components, compounds of formula (27) are obtained, as summarized in the following Table 10. TABLE 10 (27)

Example Nr. Compound Nr. A′₁ A′₂ 299 (389)

300 (390)

301 (391)

302 (392)

303 (393)

304 (394)

305 (395)

306 (396)

307 (397)

308 (398)

309 (399)

310 (340)

311 (401)

312 (402)

313 (403)

314 (404)

315 (405)

316 (406)

317 (407)

318 (408)

319 (409)

320 (410)

321 (411)

322 (412)

323 (413)

324 (414)

325 (415)

326 (416)

327 (417)

328 (418)

329 (419)

330 (420)

331 (421)

332 (422)

333 (423)

334 (424)

335 (425)

336 (426)

337 (427)

338 (428)

339 (429)

340 (430)

341 (431)

342 (432)

343 (433)

344 (434)

345 (435)

346 (436)

347 (437)

348 (438)

349 (439)

350 (440)

351 (441)

352 (442)

353 (443)

354 (444)

355 (445)

356 (446)

357 (447)

358 (448)

359 (449)

360 (450)

361 (451)

362 (452)

363 (453)

364 (454)

365 (455)

EXAMPLE 366-436

By proceeding in an analogous manner to that described in Examples 11-15, but replacing the compound of formula (100a) by the compound of formula (100J) and utilizing the appropriate coupling components, compounds of formula (28) are obtained, as summarized in the following Table 11. TABLE 11 (28)

Example Nr. Compound Nr. A′₁ A′₂ 366 (456)

367 (457)

368 (458)

369 (459)

370 (460)

371 (461)

372 (462)

373 (463)

374 (464)

375 (465)

376 (466)

377 (467)

378 (468)

379 (469)

380 (470)

381 (471)

382 (472)

383 (473)

384 (474)

385 (475)

386 (476)

387 (477)

388 (478)

389 (479)

390 (480)

391 (481)

392 (482)

393 (483)

394 (484)

395 (485)

396 (486)

397 (487)

398 (488)

399 (489)

400 (490)

401 (491)

402 (492)

403 (493)

404 (494)

405 (495)

406 (496)

407 (497)

408 (498)

409 (499)

410 (500)

411 (501)

412 (502)

413 (503)

414 (504)

415 (505)

416 (506)

417 (507)

418 (508)

419 (509)

420 (510)

421 (511)

422 (512)

423 (513)

424 (514)

425 (515)

426 (516)

427 (517)

428 (518)

429 (519)

430 (520)

431 (521)

432 (522)

433 (523)

434 (524)

435 (525)

436 (526)

APPLICATION EXAMPLES EXAMPLE 437 Unsized Without Filler

A mixture consisting of 50% long fibre spruce sulphite bleached and 50% short fibre beech sulphite bleached fibres is suspended in deionised water, as a 2% suspension, and refined and beaten to 22°SR (Schopper Riegler). After dewatering by means of a centrifuge and testing for dry weight, the equivalent to 10 g of dry fibre are placed in a beaker and made up to a volume of 500 ml with tap water. After stirring for 1 hour, 0.42%, based on the weight of dry fibre, of compound (101) as a 5 g/l aqueous solution are added to the furnish suspension and stirring continued for a further 15 minutes. The suspension is made up to 700 ml with water and from 300 ml of the resulting suspension a hand sheet is produced using a Lhomargy sheet former. After drying on a cylinder at 90° C. for 12 minutes, a greenish-yellow dyeing is obtained showing excellent bleed-fastness to water, soda and acetic acid and good light-fastness. The backwater from the dyeing is almost colourless and the degree of exhaustion amounts to 92-94%.

EXAMPLES 438-

The procedure described in Example 437 is repeated using, instead of compound (101), sufficient amounties of the appropriate dye to produce a dyeing of standard depth 0.2. The degrees of exhaustion of the respective dyes are calculated and the results summarized in Table 12 below. TABLE 12 Degree of Example Nr. Compound Nr. Exhaustion in % 438 (102) 98 439 (103) 98 440 (104) 92-94 441 (105) 98-99 442 (106) 93-94 443 (107) 93 444 (108) 92 445 (110) 98 446 (135) 97-98 447 (151) 95 448 (157) 98-99 449 (189) 95 450 (190) 97.5 451 (200) 96.5 452 (205) 97 453 (214) 95-97 453 (216) 97-98 454 (267) 93 455 (288) 98

The above results clearly demonstrate the excellent degrees of exhaustion of the dyes tested, the backwater, in all cases, being almost colourless.

EXAMPLE 456 Neutral Sized with Filler

A mixture consisting of 50% long fibre spruce sulphite bleached and 50% short fibre beech sulphite bleached fibres is suspended in deionised water, as a 2% suspension, and refined and beaten to 35°SR (Schopper Riegler). After dewatering by means of a centrifuge and testing for dry weight, the equivalent to 10 g of dry fibre and 2 g of dry chalk filler are placed in a beaker and made up to a volume of 500 ml with tap water. After stirring for 1 hour, 0.78%, based on the weight of dry fibre, of compound (101) as a 5 g/l aqueous solution are added to the furnish suspension and stirring continued for a further 15 minutes. 2% of alkyl ketene dimer size is then added, the suspension stirred for 30 minutes, 0.05% retention aid added and the suspension stirred vigorously for a further 5 minutes. The suspension is made up to 700 ml with water and from 300 ml of the resulting suspension a hand sheet is produced using a Lhomargy sheet former. After drying on a cylinder at 90° C. for 12 minutes, a greenish-yellow dyeing is obtained showing excellent fastness values. The backwater from the dyeing is only weakly coloured. 

1. A compound of the formula

in which R₁ represents hydrogen, substituted or unsubstituted C₁-C₈alkyl, substituted or unsubstituted C₁-C₈alkoxy or SO₃H, R₂ represents SO₃H or CO₂H, R₃ and R_(3a) each, independently of the other, represent hydrogen, a C₁-C₄alkyl group, which may be substituted or unsubstituted, halogen, hydroxy, substituted or unsubstituted C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl and each of the residues A₁ and A₂, independently of the other, is derived from a coupling component selected from the group consisting of an acetoacetylated amine of the formula

in which X₁ represents C₁-C₄alkyl, or phenyl which is unsubstituted or monosubstituted by C₁-C₄alkyl, C₁-C₄alkoxy or halogen and X₂ represents phenyl which is unsubstituted, mono-, di- or trisubstituted by one or two SO₃H, SO₂NHC₁-C₄ alkyl groups which alkyl groups may be substituted, SO₂C₁-C₄alkyl, C₁-C₄substituted or unsubstituted alkyl, hydroxy, C₁-C₄alkoxy, halogen, CF₃, NH₂, NHCOC₁-C₄alkyl, NHCOOC₁-C₄alkyl, NHCONHC₁-C₄alkyl, CO₂H, CONHC₁-C₄alkyl or NO₂; a 1- or 2-naphthyl residue which is unsubstituted or substituted by one or two SO₃H, SO₂NHC₁-C₄alkyl, carboxy, CONHC₁-C₄alkyl, carboxyC₁-C₄alkyl or carboxyaryl groups or a 5- or 6-membered heterocyclic ring containing 1-3 heteroatoms and which may be benzannelated and be further substituted by C₁-C₄alkyl, C₁-C₄alkoxy or halogen and which may be attached to the NH-atom in formula (2) either via the hetero- or benzo-nucleus, in the case of benzannelated heterocycles; a derivative of barbituric acid of the formula

in which Y represents O, NCN or NCONH₂; a 2,4,6-triaminopyrimidine derivative; a pyridone derivative of the formula

in which Q₁ represents hydrogen, hydroxy, C₁-C₂alkyl, hydroxyethyl, 2-(C₁-C₂alkoxy)alkyl, C₁-C₂alkoxy, COOH, CONH₂ or COOC₁-C₂alkyl, Q2 represents hydrogen, CN, CONH2, halogen, SO₃H or C₁-C₂alkyl which is unsubstituted or substituted by hydroxy, phenyl or SO₃H, Q₃ represents hydrogen, phenyl, C₁-C₂alkylphenyl, cyclohexyl or C₁-C₄alkyl which is unsubstituted or substituted by hydroxy, CN, C₁-C₂alkoxy or SO₃H and Q₄ represents hydrogen or hydroxy; an aminopyrazole or a pyrazolone derivative of formula

in which R₄ represents hydrogen, substituted or unsubstituted C₁-C₄alkyl, C₂-C₄alkenyl, NHCOC₁-C₄alkyl or CO₂H, each R₅ and R₆, independently of the other, represent hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and R₇ represents hydrogen or C₁-C₄alkyl; a benzoic acid derivative of formula

in which R₇ represents hydrogen or C₁-C₄alkyl and R₈ represents hydrogen or hydroxy or A₁ and A₂, each one independently of the other, represent a phenol residue of the formula

in which R₉ and R₁₀, each one independently of the other, represent hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen, NH₂, NHCOC₁-C₄alkyl, NO₂, SO₃H, CO₂C₁-C₄alkyl or CONHC₁-C₄alkyl groups, with the proviso that in compounds of formula

if R₁, R₂, R₃ and R_(3a) each, independently of the others, are hydrogen or SO₃H, then A₁ and A₂ are not both a 1-phenyl or 1-sulphophenyl-3-methyl-5-aminopyrazole residue, or, if R₁, R₂, R₃ and R_(3a) represent hydrogen and A₁ is a residue of formula (9) in which R₇ represents hydrogen or methyl, then A₂ does not represent a 1-phenyl or 1-sulphophenyl-3-methyl- or 3-carboxy pyrazol-5-one residue or, if R₁, R₃ and R_(3a) are hydrogen and R₂ is SO₃H and one of A₁ and A₂ represents a 1-sulphophenyl-3-methylpyrazol-5-one residue, then the other is not a residue of formula (11) in which both R₉ and R₁₀ are hydrogen, or if A₁ represents a 1-nitrophenyl-, a 1-phenyl- or an unsubstituted 3-methylpyrazol-5-one residue, A₂ is not a residue of formula (9) in which R₇ represents hydrogen, or if R₁, R₃ and R_(3a) represent hydrogen, R₂ is CO₂H and A₁ represents a residue of formula (9), in which R₇ is hydrogen, A₂ is not a residue of formula (2) or formula (7); in compounds of the formula

if R₂ represents CO₂H, R₃ represents hydroxy or methoxy and R_(3a) represents hydrogen, A₁ and A₂ do not represent residues of formulae (2) or (7) and, in compounds of the formula

if R₂ represents SO₃H and R₃ and R_(3a) both represent hydrogen A₁ and A₂ are not both 2,4-dihydroxyphenyl.
 2. A compound of formula (1), according to claim 1, which contains a total number of two, three or four SO₃H and/or CO₂H groups.
 3. A compound of the formula

according to claims 1, in which R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, R₂ represents SO₃H or CO₂H, R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy, C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, R_(3a) represents hydrogen or NH₂ and A₁ and A₂ are as defined in claim
 1. 4. A compound of formula (13), according to claim 3, in which R₃ and R_(3a) both represent hydrogen and A₁ and A₂, each one independently of the other, is derived from a coupling component selected from the group consisting of an acetoacetylated amine of the formula

in which X₁ represents C₁-C₄alkyl, and X₂ represents phenyl, which is unsubstituted, mono-, di- or trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or CO₂H; barbituric acid or cyanoiminobarbituric acid; 2,4,6-triaminopyrimidine; citrazinic acid; a pyridone derivative of the formula

in which Q₁ represents C₁-C₂alkyl, Q₂ represents CN, CONH₂ or CH₂SO₃H, Q₃ represents C₁-C₂alkyl and Q₄ represents hydroxy; an aminopyrazole or a pyrazolone derivative of formula

in which R₄ represents C₁-C₄alkyl or CO₂H, R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and R₆ represents hydrogen; a benzoic acid derivative of formula

in which R₇ represents hydrogen or C₁-C₄alkyl and R₈ represents hydrogen or hydroxy or A₁ and A₂, each one independently of the other, represent a phenol residue of the formula

in which R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or SO₃H and R₁₀ represents hydrogen.
 5. A compound of formula

according to claims 1, in which R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, R₂ represents SO₃H or CO₂H, R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy, C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, R_(3a) represents hydrogen or NH₂ and A₁ and A₂ are as defined in claim
 1. 6. A compound of formula (14), according to claim 5, in which R₃ and R_(3a) both represent hydrogen and A₁ and A₂, each one independently of the other, is derived from a coupling component selected from the group consisting of an acetoacetylated amine of the formula

in which X₁ represents C₁-C₄alkyl, and X₂ represents phenyl, which is unsubstituted, mono-, di- or trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or CO₂H; barbituric acid or cyanoiminobarbituric acid; 2,4,6-triaminopyrimidine; citrazinic acid; an aminopyrazole or a pyrazolone derivative of formula

in which R₄ represents C₁-C₄alkyl or CO₂H, R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and R₆ represents hydrogen; a benzoic acid derivative of formula

in which R₇ represents hydrogen or C₁-C₄alkyl and R₈ represents hydrogen or hydroxy or A₁ and A₂, each one independently of the other, represent a phenol residue of the formula

in which R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or SO₃H and R₁₀ represents hydrogen.
 7. A compound of formula

according to claim 1, in which R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, R₂ represents SO₃H or CO₂H, R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy, C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, R_(3a) represents hydrogen or NH₂ and A₁ and A₂ are as defined in claim
 1. 8. A compound of formula (15), according to claim 7, in which R₃ and R_(3a) both represent hydrogen and A₁ and A₂, each one independently of the other, is derived from a coupling component selected from the group consisting of an acetoacetylated amine of the formula

in which X₁ represents C₁-C₄alkyl, and X₂ represents phenyl, which is unsubstituted, mono-, di- or trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or CO₂H; barbituric acid or cyanoiminobarbituric acid; 2,4,6-triaminopyrimidine; citrazinic acid; an aminopyrazole or a pyrazolone derivative of formula

in which R₄ represents C₁-C₄alkyl or CO₂H, R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and R₆ represents hydrogen; a benzoic acid derivative of formula

in which R₇ represents hydrogen or C₁-C₄alkyl and R₈ represents hydrogen or hydroxy or A₁ and A₂, each one independently of the other, represent a phenol residue of the formula

in which R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or SO₃H and R₁₀ represents hydrogen.
 9. A compound of formula

according to claim 1, in which R₁ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy or SO₃H, R₂ represents SO₃H or CO₂H, R₃ represents hydrogen, a C₁-C₄alkyl group, halogen, hydroxy, C₁-C₄alkoxy, carboxy, NH₂ or NHC₁-C₄alkyl, R_(3a) represents hydrogen or NH₂ and A₁ and A₂ are as defined in claim
 1. 10. A compound of formula (16), according to claim 9, in which R₃ and R_(3a) both represent hydrogen and A₁ and A₂, each one independently of the other, is derived from a coupling component selected from the group consisting of an acetoacetylated amine of the formula

in which X₁ represents C₁-C₄alkyl, and X₂ represents phenyl, which is unsubstituted, mono-, di- or trisubstituted by SO₃H, C₁-C₄alkyl, hydroxy, C₁-C₄alkoxy, halogen or CO₂H; barbituric acid or cyanoiminobarbituric acid; 2,4,6-triaminopyrimidine; citrazinic acid; an aminopyrazole or a pyrazolone derivative of formula

in which R₄ represents C₁-C₄alkyl or CO₂H, R₅ represents hydrogen, halogen, C₁-C₄alkyl, SO₃H or CO₂H and R₆ represents hydrogen; a benzoic acid derivative of formula

in which R₇ represents hydrogen or C₁-C₄alkyl and R₈ represents hydrogen or hydroxy or A₁ and A₂, each one independently of the other, represent a phenol residue of the formula

in which R₉ represents hydrogen, C₁-C₄alkyl, C₁-C₄alkoxy, hydroxy, halogen or SO₃H and R₁₀ represents hydrogen.
 11. A process for the preparation of a compound of formula (1), according to claim 1, by tetrazotisation of a diaminobenzanilide derivative of the formula

in which R₁, R₂, R₃ and R_(3a) are as defined in claim 1, and sequential coupling with a coupling component of the formula A₁H or A₂H, followed by coupling with a coupling component of the formula A₂H or A₁H, A₂ and A₁ being as defined in claim
 1. 12. A compound of the formula


13. A process for the preparation of compound (18), according to claim 12, by reaction of 2-methoxy-4-nitroaniline-5-sulphonic acid with the appropriate nitrobenzoyl halide, followed by reduction of the resulting dintrobenzanilide.
 14. (canceled)
 15. A process for dyeing natural or synthetic materials, comprising contacting said materials with a tinctorially effective amount of a compound of the formula (1) according to claim 1, and, optionally, further auxiliaries.
 16. A solid dye preparation for dyeing paper, comprising a compound of the formula (1) according to claim 1, and, optionally, further auxiliaries.
 17. Aqueous solutions for dyeing paper, comprising a compound of the formula (1), according to claim 1, and, optionally, further auxiliaries.
 18. Aqueous solutions according to claim 17 containing, as further auxiliaries, solubilizers and/or organic solvents.
 19. Paper which is dyed with a compound of the formula (1), according to claim
 1. 20. A process for the preparation of a compound of formula (1), according to claim 1, by tetrazotisation of a diaminobenzanilide derivative of the formula

and sequential coupling with a coupling component of the formula A₁H or A₂H, followed by coupling with a coupling component of the formula A₂H or A₁H, A₂ and A₁ being as defined in claim
 1. 